Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.52 |
| ▸ | LMNA | P02545 | 2/20 | 0.52 |
| ▸ | SMN1; SMN2 | Q16637 | 8/20 | 0.47 |
| ▸ | AXL | P30530 | 1/20 | 0.43 |
| ▸ | GFER | P55789 | 1/20 | 0.43 |
| ▸ | TP53 | P04637 | 3/20 | 0.37 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.37 |
| ▸ | TSHR | P16473 | 1/20 | 0.37 |
| ▸ | RAB9A | P51151 | 6/20 | 0.37 |
| ▸ | NPC1 | O15118 | 5/20 | 0.37 |
| ▸ | SCN4A | P35499 | 3/20 | 0.37 |
| ▸ | GAA | P10253 | 2/20 | 0.37 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.37 |
| ▸ | GMNN | O75496 | 1/20 | 0.37 |
| ▸ | USP2 | O75604 | 1/20 | 0.37 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.37 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.37 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.37 |
| ▸ | PKM | P14618 | 1/20 | 0.37 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18769980 | 0.83 | SMN1; SMN2 (0.43) | ALDH1A1LMNASMN1; SMN2AXLGFER | |
| SCHEMBL17839794 | 0.83 | SMN1; SMN2 (0.43) | ALDH1A1LMNASMN1; SMN2AXLGFER | |
| SCHEMBL25423809 | 0.81 | SMN1; SMN2 (0.44) | ALDH1A1LMNASMN1; SMN2AXLGFER | |
| SCHEMBL27051748 | 0.79 | SMN1; SMN2 (0.44) | ALDH1A1LMNASMN1; SMN2AXLGFER | |
| SCHEMBL17609992 | 0.76 | AXL (0.47) | ALDH1A1LMNASMN1; SMN2AXLGFER | |
| SCHEMBL20969605 | 0.76 | ALDH1A1 (0.35) | ALDH1A1LMNA | |
| SCHEMBL1748005 | 0.76 | SMN1; SMN2 (0.47) | ALDH1A1LMNASMN1; SMN2AXLGFER | |
| SCHEMBL30389176 | 0.76 | SMN1; SMN2 (0.47) | ALDH1A1LMNASMN1; SMN2AXLGFER | |
| SCHEMBL18614481 | 0.73 | SMN1; SMN2 (0.44) | ALDH1A1LMNASMN1; SMN2AXLGFER | |
| SCHEMBL18791318 | 0.73 | SMN1; SMN2 (0.49) | ALDH1A1LMNASMN1; SMN2AXLGFER |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4722205-A1 | HETEROCYCLIC COMPOUND AND NOXIOUS ARTHROPOD-CONTROLLING COMPOSITION CONTAINING SAME | Sumitomo Chemical Company, Limited (JP) | 2026-04-08 | — | — | EP | disclosed |
| WO-2024248015-A1 | HETEROCYCLIC COMPOUND AND NOXIOUS ARTHROPOD-CONTROLLING COMPOSITION CONTAINING SAME | 住友化学株式会社 | 2024-12-05 | — | — | WO | disclosed |
| US-20150011528-A1 | PHENYLIMIDE-CONTAINING BENZOTHIAZOLE DERIVATIVE OF ITS SALT AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME | YUHAN CORPORATION (KR) | 2015-01-08 | — | — | US | disclosed |
| EP-2758384-A1 | PHENYLIMIDE-CONTAINING BENZOTHIAZOLE DERIVATIVE OR ITS SALT AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME | Yuhan Corporation (KR) | 2014-07-30 | — | — | EP | disclosed |
| WO-2013043001-A1 | PHENYLIMIDE-CONTAINING BENZOTHIAZOLE DERIVATIVE OR ITS SALT AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME | YUHAN CORPORATION (KR) | 2013-03-28 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150011528-A1 | PHENYLIMIDE-CONTAINING BENZOTHIAZOLE DERIVATIVE OF ITS SALT AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME | ILK, PKMYT1, PLAUR | ALDH1A1 3792/4885LMNA 598/4885SMN1; SMN2 2126/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.